awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27645052-5D3EBD23-1F07-4FEF-892F-C8E3B47A5087
Q27645052-5D3EBD23-1F07-4FEF-892F-C8E3B47A5087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27645052-5D3EBD23-1F07-4FEF-892F-C8E3B47A5087
X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir
P2860
Q27645052-5D3EBD23-1F07-4FEF-892F-C8E3B47A5087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27645052-5D3EBD23-1F07-4FEF-892F-C8E3B47A5087
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d03eaca7a7aca73457297c9c72d4a892df2342d
P2860
Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects.